Lidocaine Accord

Lidocaine, the active ingredient in Lidocaine Accord, is a local anesthetic presented as a sterile solution for epidural, intramuscular and intravenous use. It provides rapid onset of sensory nerve block and is employed to achieve local and regional anesthesia in surgical and diagnostic procedures.

GNH USA supplies Lidocaine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Customers benefit from reliable supply chains and responsive technical support.

Lidocaine Accord is used in the local anesthetic pathway to provide reversible nerve block for various clinical situations. - Local anesthesia: produces temporary loss of sensation for minor surgical or diagnostic procedures. - Regional anesthesia: enables epidural or spinal block for obstetric, orthopedic or abdominal surgeries. - Pain management: administered intravenously to reduce acute postoperative or neuropathic pain.

Lidocaine Accord may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tingling or numbness at the injection site - Light‑headedness or dizziness - Nausea or metallic taste - Mild hypotension - Headache - Transient visual disturbances

Serious or Rare Side Effects: - Seizures or convulsions - Cardiac arrhythmias, including ventricular tachycardia - Respiratory depression or apnea - Severe allergic reactions such as anaphylaxis - Methemoglobinemia - Cardiovascular collapse

When using Lidocaine Accord, several precautions should be observed to minimize risk and ensure safe administration. - Assess allergy: verify patient has no known hypersensitivity to lidocaine or amide‑type anesthetics. - Monitor cardiac status: observe ECG and blood pressure during intravenous or epidural administration. - Limit dose: adhere to recommended maximum cumulative dose based on patient weight and route. - Adjust for hepatic impairment: reduce dose or extend interval in patients with liver dysfunction. - Caution in cardiac disease: avoid use in severe heart block or uncontrolled arrhythmias unless benefits outweigh risks. - Store at room temperature: keep in original container, protect from light and moisture, and do not freeze.

Lidocaine can interact with other medicines, influencing its plasma concentration or enhancing toxic effects.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of cardiotoxicity. - Beta‑blockers (e.g., propranolol): may potentiate hypotensive and bradycardic effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): elevate lidocaine levels.

Moderate Interactions (Monitor Closely): - Concurrent use of other local anesthetics: additive central nervous system and cardiac toxicity. - Diuretics (e.g., furosemide): may alter plasma protein binding and increase free lidocaine. - General anesthetics (e.g., propofol, volatile agents): synergistic depression of central nervous system.